Epigenetic mechanisms in mood disorders: Targeting neuroplasticity
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Developing novel therapeutics and diagnostic tools based upon an understanding of neuroplasticity is critical in order to improve the treatment and ultimately the prevention of a broad range of nervous system disorders. In the case of mood disorders, such as major depressive disorder and bipolar disorder, where diagnoses are based solely on nosology rather than pathophysiology, there exists a clear unmet medical need to advance our understanding of the underlying molecular mechanisms and to develop fundamentally new mechanism experimental medicines with improved efficacy. In this context, recent preclinical molecular, cellular, and behavioral findings have begun to reveal the importance of epigenetic mechanisms that alter chromatin structure and dynamically regulate patterns of gene expression that may play a critical role in the pathophysiology of mood disorders. Here, we will review recent advances involving the use of animal models in combination with genetic and pharmacological probes to dissect the underlying molecular mechanisms and neurobiological consequence of targeting this chromatin-mediated neuroplasticity. We discuss evidence for the direct and indirect effects of mood stabilizers, antidepressants, and antipsychotics, among their many other effects, on chromatin-modifying enzmyes and on the epigenetic state of defined genomic loci, in defined cell types and in specific regions of the brain. These data, as well as findings from patient-derived tissue, have also begun to reveal alterations of epigenetic mechanisms in the pathophysiology and treatment of mood disorders. We summarize growing evidence supporting the notion that selectively targeting chromatin-modifying complexes, including those containing histone deacetylases (HDACs), provides a means to reversibly alter the acetylation state of neuronal chromatin and benefically impact neuronal activity-regulated gene transcription and mood-related behaviors. Looking beyond current knowledge, we discuss how high-resolution, whole-genome methodologies, such as RNA-sequencing (RNA-Seq) for transcriptome analysis and chromatin immunoprecipitation-sequencng (ChIP-Seq) for analyzing genome-wide occupancy of chromatin-associated factors, are beginning to provide an unprecedented view of both specific genomic loci as well as global properties of chromatin in the nervous system. These methodologies when applied to the characterization of model systems, including those of patient-derived induced pluripotent (iPS) cell and induced neurons (iNs), will greatly shape our understanding of epigenetic mechanisms and the impact of genetic variation on the regulatory regions of the human genome that can affect neuroplasticty. Finally, we point out critical unanswered questions and areas where additional data are needed in order to better understand the potential to target mechanisms of chromatin-mediated neuroplasticity for novel treatments of mood and other psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“Despite intensive basic research and clinical studies, our understanding of the etiology and pathophysiology of mood disorders is severely limited (Manji and Duman, 2001, Quiroz and Manji, 2002, Krishnan and Nestler, 2008, Pittenger and Duman, 2008).”
BackgroundThe Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
The development and application of optogenetics
Fenno, L., Yizhar, O., & Deisseroth, K. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113817 · Cited by 1,822 · cited 2×
“half-lives) that provide varying levels of exposure provide an example of such temporal control, it also would be highly desirable to identify probes whose properties could be selectively activated or inhibited much the same way that, for example, optogenetic methods provide control of neuronal firing (Fenno et al., 2…”
BackgroundStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · cited 2×
“Despite intensive basic research and clinical studies, our understanding of the etiology and pathophysiology of mood disorders is severely limited (Manji and Duman, 2001, Quiroz and Manji, 2002, Krishnan and Nestler, 2008, Pittenger and Duman, 2008).”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 8×
“It is interesting to note that the original work from the Nestler laboratory demonstrating a role of HDACs in social defeat model of depression was using Hdac5 and the work from the Berton laboratory was on Hdac6— both of which are Class II HDACs that has been shown consistently by multiple groups to not be inhibited…”
BackgroundInfluentialPhiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 1×
“First, the anticonvuldant and antimanic/mood stabilizing valproic acid inhibits Class I HDACs but not Class II-IV HDACs (Phiel et al., 2001).”
BackgroundHDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644 · cited 5×
“As part of these studies, it was demonstrated that Hdac2 overexpression causes a loss of synapse number and decreased memory formation, whereas conversely Hdac2 deficiency caused an increase in synapse number and enhanced memory formation using a fear conditioning paradigm (Guan et al., 2009).”
BackgroundMethodInfluentialSelf-citationNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 3×
“…is that gaining a deep understanding of the underlying molecular mechanisms will provide insight that will allow the future development of novel methods for therapeutic intervention in mood disorders (Berton and Nestler, 2006, Tsankova et al., 2007, Haggarty and Tsai, 2011, Houston et al., 2012).”
BackgroundNakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L. P., & Sassone-Corsi, P. (2008) · Cell · doi:10.1016/j.cell.2008.07.002 · Cited by 1,427 · cited 13×
“CLOCK also acetylates BMAL1, which has the effect of repressing CLOCK-BMAL1-mediated transcription (Hirayama et al., 2007).”
BackgroundInfluentialEpigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · cited 3×
“…tool kit, given the recognition of the importance of epigenetic mechanisms in the response to stress and in depressive-like behaviors (Tsankova et al., 2007, Covington et al., 2010, Sun et al., 2012), there has been significant efforts put forth toward the use of these prototypical…”
BackgroundMethodPositional Cloning of the Mouse Circadian Gene
King, D. P., Zhao, Y., Sangoram, A. M., Wilsbacher, L. D., Tanaka, M., Antoch, M. P., Steeves, T. D. L., Vitaterna, M. H., Kornhauser, J. M., Lowrey, P. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80245-7 · Cited by 1,382
Psychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., Edenberg, H. J., Nurnberger, J. I., Rietschel, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.943 · Cited by 1,344
Self-citationJudd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243 · cited 1×
“In the case of BPD, which involves both manic and depressive episodes, longitudinal studies indicate that patients with BPD I and II are burdened by significant depressive symptoms for much of their course despite standard treatments (Judd et al., 2002, Judd et al., 2003).”
BackgroundRecovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227 · cited 2×
“…and memory formation, and inspired by the remarkable ability of sodium butyrate to provide access to memories even in the face of neurodegeneration (Fischer et al., 2007), studies that have used gain-of-function and loss-of-function mouse models have identified a key role of Hdac2, but not Hdac1,…”
BackgroundRegulation of histone acetylation during memory formation in the hippocampus
Levenson, J. M., O'Riordan, K. J., Brown, K. D., Trinh, M. A., Molfese, D. L., & Sweatt, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402229200 · Cited by 1,131 · cited 5×
“Additional pioneering work in this area by Sweatt and colleagues demonstrated that the acetylation of histone H3 in area CA1 of the hippocampus was increased upon contextual fear conditioning in a manner dependent upon activation of the NMDA receptor and Erk1/2 kinase activity (Levenson et al., 2004).”
BackgroundInfluentialExcess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · cited 1×
“These symptoms contribute to the substantial morbidity and mortality observed in bipolar disorder, including persistent functional impairment (Tohen et al., 2000) as well as suicide (Osby et al., 2001).”
BackgroundEffectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937 · cited 1×
“Specifically, standard antidepressants have repeatedly failed to show benefit in randomized, controlled trials (Nemeroff et al., 2001, Sachs et al., 2007).”
BackgroundChromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice
Alarcón, J. M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E. R., & Barco, A. (2004) · Neuron · doi:10.1016/j.neuron.2004.05.021 · Cited by 892 · cited 3×
“As demonstrated by a series of studies (Alarcon et al., 2004) (Wood et al.”
BackgroundRequirement of a Critical Period of Transcription for Induction of a Late Phase of LTP
Nguyen, P. V., Abel, T., & Kandel, E. R. (1994) · Science · doi:10.1126/science.8066450 · Cited by 888
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., et al. (2012) · Nature · doi:10.1038/nature10849 · Cited by 853 · cited 2×
“…virus-mediated delivery of a shorthairpin-RNA (shRNA) that selectively targets Hdac2 into the hippocampus of adult mice was sufficient to restore synaptic plasticity deficits, enhance synaptogenesis, and ameliorate behavioral deficits in a mouse model of neurodegeneration (Graff et al., 2012).”
BackgroundSelf-citationCBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation
Korzus, E., Rosenfeld, M. G., & Mayford, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.002 · Cited by 823 · cited 1×
“The initial evidence for this came from studies of the role of chromatin in learning and memory (Guan et al., 2002, Alarcon et al., 2004, Korzus et al., 2004, Levenson et al., 2004, Levenson and Sweatt, 2005, Wood et al., 2005, Vecsey et al., 2007, Day and Sweatt, 2011).”
BackgroundMania-like behavior induced by disruption of CLOCK
Roybal, K., Theobold, D., Graham, A., DiNieri, J. A., Russo, S. J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609625104 · Cited by 803
Epigenetic mechanisms in memory formation
Levenson, J. M., & Sweatt, J. D. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1604 · Cited by 767 · cited 1×
“The initial evidence for this came from studies of the role of chromatin in learning and memory (Guan et al., 2002, Alarcon et al., 2004, Korzus et al., 2004, Levenson et al., 2004, Levenson and Sweatt, 2005, Wood et al., 2005, Vecsey et al., 2007, Day and Sweatt, 2011).”
BackgroundFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“…activity toward histone substrates is mediated through a Class I HDAC3, which interacts with Class IIa HDACs via the nuclear corepressor NCoR, and that Class IIa HDACs may naturally target substrates other than histones despite their orginal namesake (Fischle et al., 2002, Verdin et al., 2003).”
BackgroundChemical phylogenetics of histone deacetylases
Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., & Mazitschek, R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.313 · Cited by 720 · cited 15×
“It is interesting to note that the original work from the Nestler laboratory demonstrating a role of HDACs in social defeat model of depression was using Hdac5 and the work from the Berton laboratory was on Hdac6— both of which are Class II HDACs that has been shown consistently by multiple groups to not be inhibited…”
BackgroundInfluentialSelf-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689 · cited 1×
“Depressive episodes are typically recurrent, and may be chronic as well (Perlis et al., 2006).”
BackgroundSelf-citationClass II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664 · cited 1×
“…activity toward histone substrates is mediated through a Class I HDAC3, which interacts with Class IIa HDACs via the nuclear corepressor NCoR, and that Class IIa HDACs may naturally target substrates other than histones despite their orginal namesake (Fischle et al., 2002, Verdin et al., 2003).”
BackgroundAntidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624 · cited 7×
“Paralleling these genetic manipulations, the systemic administration of the non-selective HDAC inhibitor SAHA for the last 5 days of each 6-week CUMS sessions and during behavioral testing had antidepressant like activity in the social interaction, sucrose preference, FST, and noveltysuppressed feeding tests (Uchida e…”
BackgroundInfluentialSelf-citationThase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559 · cited 1×
“Finally, the majority of subjects in atypical antipsychotic studies still fail to achieve euthymia (Tohen et al., 2003, Thase et al., 2006, Vieta et al., 2007, Weisler et al., 2008), metabolic risks are substantial (Newcomer, 2005), and rates of discontinuation are high (Scherk et al., 2007).”
BackgroundAntidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541 · cited 4×
“Most exciting from a therapeutic perspective, administration of an Hdac6-specific inhibitor, NCT-14b, had antidepressant-like behavioral effects in the TST in mice in a manner that was correlated with changes in cytoplasmic tubulin acetylation and could be phenocopied by the complete knockout of Hdac6 (Fukada et al.,…”
BackgroundResultInfluentialSelf-citationEpigenetic mechanisms in cognition
Day, J. J., & Sweatt, J. D. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.019 · Cited by 510
HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation
McQuown, S. C., Barrett, R. M., Matheos, D. P., Post, R. J., Rogge, G. A., Alenghat, T., Mullican, S. E., Jones, S., Rusche, J. R., Lazar, M. A., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5052-10.2011 · Cited by 507
Guan, Z., Giustetto, M., Lomvardas, S., Kim, J.-H., Miniaci, M. C., Schwartz, J. H., Thanos, D., & Kandel, E. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01074-7 · Cited by 497 · cited 8×
“Following the observation of differential epigenetic state of chromatin in mood disorder subjects, profiling of the mRNA levels of 11 HDACs (HDAC1-11) in peripheral white blood cells of MDD and BPD subjects during depressive and rperiods of symptomatic remission has revealed that HDAC2 and HDAC5 mRNA levels are decrea…”
BackgroundInfluentialTsankova, N. M., Kumar, A., & Nestler, E. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0589-04.2004 · Cited by 447
Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications
Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., & Shiekhattar, R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.004 · Cited by 438
Epigenetics of the depressed brain: role of histone acetylation and methylation
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.73 · Cited by 413 · cited 2×
“…the importance of epigenetic mechanisms in the response to stress and in depressive-like behaviors (Tsankova et al., 2007, Covington et al., 2010, Sun et al., 2012), there has been significant efforts put forth toward the use of these prototypical pharmacological probes to target HDAC-mediated…”
BackgroundUchida, S., Hara, K., Kobayashi, A., Otsuki, K., Yamagata, H., Hobara, T., Suzuki, T., Miyata, N., & Watanabe, Y. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.023 · Cited by 398
The role of cognitive impairment in general functioning in major depression
Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · cited 1×
“During mood episodes, individuals with MDD or BPD often experience cognitive dysfunction, particularly individuals with BPD who may experience residual cognitive symptoms between episodes even in the absence of other prominent mood symptoms (Zarate et al., 2000, Baune et al., 2010).”
BackgroundIsoform-selective histone deacetylase inhibitors
Bieliauskas, A. V., & Pflum, M. K. H. (2008) · Chemical Society Reviews · doi:10.1039/b703830p · Cited by 350 · cited 1×
“Most HDAC inhibitors function through chelating the active site zinc ion, and on the basis of the structures of these inhibitors, a general model for HDAC inhibitors has been put forth consisting of “cap-linker-chelators” moieties (Bieliauskas and Pflum, 2008).”
BackgroundRegulation of hippocampal H3 histone methylation by acute and chronic stress
Hunter, R. G., McCarthy, K. J., Milne, T. A., Pfaff, D. W., & McEwen, B. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911143106 · Cited by 290
A Role for Repressive Histone Methylation in Cocaine-Induced Vulnerability to Stress
Covington, H. E., Maze, I., Sun, H., Bomze, H. M., DeMaio, K. D., Wu, E. Y., Dietz, D. M., Lobo, M. K., Ghose, S., Mouzon, E., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.007 · Cited by 289 · cited 2×
“Finally, the expression of several chromatinmodifying enzymes (HDACs or KDMs) is altered in MDD and BD in peripheral blood lymphocytes or post-mortem brain tissue (Iga et al., 2007, Hobara et al., 2010, Abe et al., 2011, Covington et al., 2011).”
BackgroundWilkinson, M. B., Xiao, G., Kumar, A., LaPlant, Q., Renthal, W., Sikder, D., Kodadek, T. J., & Nestler, E. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0932-09.2009 · Cited by 262 · cited 2×
“…defeat resulted in increased promoter region histone methylation (H3K9me2 and H3K27me2) on number of genes in the nucleus accumbens and that chromatin changes were similar between mice treated with imipramine compared to those animals resilient to the social defeat model (Wilkinson et al., 2009).”
BackgroundScherk, H., Pajonk, F. G., & Leucht, S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.442 · Cited by 243 · cited 2×
“Finally, the majority of subjects in atypical antipsychotic studies still fail to achieve euthymia (Tohen et al., 2003, Thase et al., 2006, Vieta et al., 2007, Weisler et al., 2008), metabolic risks are substantial (Newcomer, 2005), and rates of discontinuation are high (Scherk et al., 2007).”
BackgroundGlutamatergic Modulators: The Future of Treating Mood Disorders?
Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., & Salvadore, G. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.511059 · Cited by 228 · cited 1×
“…as shown by the effectiveness of electroconvulsive therapy (Dierckx et al., 2012), the effects of glutamatergic antidepressants such as ketamine (Zarate et al., 2010), and the repeated observation that more that a third of individuals with MDD do not achieve symptomatic remission with…”
BackgroundEfficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta‐analysis
Dierckx, B., Heijnen, W. T., van den Broek, W. W., & Birkenhäger, T. K. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00997.x · Cited by 224 · cited 2×
“However, despite the wealth of data supporting the role of aberrant monoaminergic system in the pathophysiology of MDD, directly targeting these mechanisms of synaptic transmission is neither necessary nor sufficient for clinical efficacy, as shown by the effectiveness of electroconvulsive therapy (Dierckx et al., 201…”
BackgroundAltered gene expression of histone deacetylases in mood disorder patients
Hobara, T., Uchida, S., Otsuki, K., Matsubara, T., Funato, H., Matsuo, K., Suetsugi, M., & Watanabe, Y. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.015 · Cited by 185
Altered sirtuin deacetylase gene expression in patients with a mood disorder
Abe, N., Uchida, S., Otsuki, K., Hobara, T., Yamagata, H., Higuchi, F., Shibata, T., & Watanabe, Y. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.01.016 · Cited by 131 · cited 3×
“Finally, the expression of several chromatinmodifying enzymes (HDACs or KDMs) is altered in MDD and BD in peripheral blood lymphocytes or post-mortem brain tissue (Iga et al., 2007, Hobara et al., 2010, Abe et al., 2011, Covington et al., 2011).”
BackgroundResultYamawaki, Y., Fuchikami, M., Morinobu, S., Segawa, M., Matsumoto, T., & Yamawaki, S. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.585663 · Cited by 117 · cited 2×
“While one recent study indicates that sodium butyrate, at a dose sufficient to induce histone acetylation in mouse brain, did not alter FST behavioral response after a 21 day treatment paradigm (Gundersen and Blendy, 2009), another recapitulates antidepressant-like effects chronic butyrate treatment in the FST and TST…”
BackgroundEffects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety
Gundersen, B. B., & Blendy, J. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.008 · Cited by 112 · cited 1×
“…at a dose sufficient to induce histone acetylation in mouse brain, did not alter FST behavioral response after a 21 day treatment paradigm (Gundersen and Blendy, 2009), another recapitulates antidepressant-like effects chronic butyrate treatment in the FST and TST and further shows…”
BackgroundAltered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression
Iga, J.-I., Ueno, S.-I., Yamauchi, K., Numata, S., Kinouchi, S., Tayoshi-Shibuya, S., Song, H., & Ohmori, T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.014 · Cited by 105 · cited 1×
“Finally, the expression of several chromatinmodifying enzymes (HDACs or KDMs) is altered in MDD and BD in peripheral blood lymphocytes or post-mortem brain tissue (Iga et al., 2007, Hobara et al., 2010, Abe et al., 2011, Covington et al., 2011).”
BackgroundFrom synapse to nucleus: Novel targets for treating depression
Covington, H. E., Vialou, V., & Nestler, E. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.004 · Cited by 98
Valproic Acid Phase Shifts the Rhythmic Expression of PERIOD2::LUCIFERASE
Johansson, A.-S., Brask, J., Owe-Larsson, B., Hetta, J., & Lundkvist, G. B. S. (2011) · Journal of Biological Rhythms · doi:10.1177/0748730411419775 · Cited by 97 · cited 1×
“Indeed, valproic acid does regulate circadian rhythmicity in mouse embryonic fibroblast reporter gene cells (Johansson et al., 2011), suggesting that it might alter the circadian rhythm deregulation in CLOCKΔ19 mice that underlies their manic-like behavior.”
BackgroundEgan, M., Goldman, D., & Weinberger, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.12 · Cited by 20
Cited by
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
“Accordingly, epigenetic mechanisms have been linked to the persistent synaptic plasticity changes associated with depressive-like behaviors (Bagot et al., 2014, Fass et al., 2014) and gender differences in stress responses (Hodes, 2013, Hunter and McEwen, 2013).”
BackgroundEpigenetics across the human lifespan
Kanherkar, R. R., Bhatia-Dey, N., & Csoka, A. B. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00049 · Cited by 407
DNA methylation, early life environment, and health outcomes
Mitchell, C., Schneper, L. M., & Notterman, D. A. (2016) · Pediatric Research · doi:10.1038/pr.2015.193 · Cited by 146
“Will measuring epigenetic changes provide a target for intervening to attenuate the health effects of environmental stressors (70,106)? We have made reference to the observation that folic acid supplementation reverses changes in DNA methylation (and RNA expression) associated with maternal protein restriction (103).”
BackgroundVisualizing epigenetics: Current advances and advantages in HDAC PET imaging techniques
Wang, C., Schroeder, F. A., & Hooker, J. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.018 · Cited by 48
Self-citationZhao, W.-N., Ghosh, B., Tyler, M., Lalonde, J., Joseph, N. F., Kosaric, N., Fass, D. M., Tsai, L.-H., Mazitschek, R., & Haggarty, S. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00116 · Cited by 35
Self-citation
Metadata
- Authors
- Fass, D. M., Schroeder, F. A., Perlis, R. H., & Haggarty, S. J.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 264
- Pages
- 112-130
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2014559152
- Cited by
- 62
- References
- 54
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.